Taking the Pulse, A Health Care and Life Sciences Video Podcast | Episode 178: Life Sciences Industry Impact with Bob Coughlin, JLL Director and Former MassBio CEO
Taking the Pulse, A Health Care and Life Sciences Video Podcast | Episode 174: Artificial Intelligence in Healthcare with Jonathan Samples, Partner at 121G
Episode 172: Matthew Roberts and Lauren DeMoss, Maynard Nexsen Health Care Attorneys
Podcast: Telehealth Post-Public Health Emergency – What to Expect in 2024 – Diagnosing Health Care
Health + Tech - Future of Precision Medicine With Dr. Amrie Grammer
Episode 161: David Garrett and Stephen Davis, Maynard Nexsen Immigration Attorneys
Podcast - Digital Health Market Assessment
Quick Takeaways From the 2024 Proposed Hospice Wage Index Rule
Patient Data and Privacy
Changing Telehealth Rules
Telehealth Risk Report: What the Government Found
The End of COVID Waivers and Exceptions: What Now?
Taking the Pulse, A Health Care and Life Sciences Video Podcast | Episode 118: Matthew Roberts and Darra Coleman, Health Care Attorneys, Nexsen Pruet
HIPAA Tips With Williams Mullen - Telehealth After the Pandemic
JONES DAY PRESENTS®: Tax Implications of Telehealth as Remote Services Become Norm
Taking the Pulse, A Health Care and Life Sciences Video Podcast | Episode 106: Dr. James McElligott, MUSC & Dr. Shawn Stinson, BlueCross BlueShield of SC
Hybrid Workforces and Compliance with Sheila Limmroth
[Podcast] Raul Ordonez on Telehealth
Update and Discussion on Legal and Practical Issues
Video: Leaders Moving Business Forward Featuring Clear Eye Test
Join us for an insightful webinar as we delve into the ever-evolving landscape of telehealth in 2024. In this session, Carrie Foote and Paul Schmeltzer will explore the latest trends shaping telehealth, including advancements...more
Today, a tale of two markets are seen in healthcare mergers and acquisition (M&A): the present (as reflected in the data about declining dealmaking) and the future (reflected in the increasingly positive outlook by...more
Providers and platforms should know that healthcare in the metaverse — which may involve telepresence, digital twinning, and blockchain — is subject to ‘real life’ regulations. The metaverse uses technologies such as...more
Come together with key decision-makers, innovators and investors from across the healthcare, life sciences and private equity (PE) industries during the year’s largest healthcare investment symposium....more
Join Manatt for the Second of Our Imperatives Deep-Dive Sessions on the Topics You Voted Most Important to You. Strengthening our nation’s long-term care system is a pressing societal issue as growing numbers of older...more
The U.S. Department of Justice (“DOJ”) recently announced that over $5.6 billion in False Claims Act (“FCA”) settlements and judgments had been reached during the 2021 fiscal year, with over $5 billion of those settlements...more
Digital health technologies are revolutionizing the global health environment by advancing healthcare services, Big Data analytics and medical device development and innovation, expanding the reach, accessibility and...more
Watch episode 3 of our Health+Tech video series, where McGuireWoods partner Andrea Lee Linna and Ludi founder and CEO Gail Peace discuss how technology can further healthcare compliance....more
Watch episode 2 of McGuireWoods’ video series Health+Tech, “Edge of Digital Health Transformation.” Host and McGuireWoods partner Jonathan Ishee discusses key issues in the digital health space with healthcare IT executive...more
The healthcare industry is rapidly changing, and digital health acumen is becoming crucial to success. 2020 has led to significant changes in healthcare delivery, and healthcare organizations are turning to data-driven...more
You won’t want to miss four days of exclusive, virtual events that bring together industry leaders, emerging standouts, innovators and investors from across the industry landscape at the largest healthcare investment...more
Report on Research Compliance 17, no. 12 (December 2020) - Finalizing a document issued last year, on Nov. 9 the Food and Drug Administration issued “Enhancing the Diversity of Clinical Trial Populations—Eligibility...more
We are pleased to provide you with the third annual installment of our Life Sciences and Health Care Horizons guide. For each of these guides, we have asked our industry thought leaders throughout the world to write about...more